Kraków, Poland

Jolanta Jaśkowska


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jolanta Jaśkowska: Innovator in CNS Treatment

Introduction

Jolanta Jaśkowska is an accomplished inventor based in Kraków, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of central nervous system (CNS) diseases. With two patents to her name, her work is paving the way for new therapeutic options.

Latest Patents

Among her latest patents are arylosulfonamides designed for the treatment of CNS diseases. These arylsulphonamide derivatives, classified under formula (I) and their pharmaceutically acceptable salts, showcase the potential for addressing various CNS disorders. The compounds aim to provide effective treatments and preventive measures, thereby enhancing the quality of life for individuals suffering from such ailments. Interestingly, both patents focus on the same innovative compounds, underscoring their importance within her research endeavors.

Career Highlights

Jolanta is currently associated with Adamed Sp. z o.o., a company recognized for its commitment to innovative healthcare solutions. Her work at Adamed showcases her dedication to advancing medical science and bringing new treatments to the market.

Collaborations

In her professional journey, Jolanta collaborates with esteemed colleagues such as Piotr Kowalski and Monika Marcinkowska. This teamwork not only enhances her research capabilities but also fosters a collaborative environment that inspires creativity and innovation.

Conclusion

Jolanta Jaśkowska is an example of how dedicated inventors can significantly impact the medical landscape. Through her patents and collaborations, she continues to contribute to the betterment of healthcare solutions for CNS diseases, proving that innovation and teamwork can lead to remarkable advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…